|
Volumn 50, Issue 78, 2014, Pages 11465-11468
|
Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLIC ARGININE-GLYCINE-ASPARTIC ACID PEPTIDE;
CYCLOPEPTIDE;
DOXORUBICIN;
DRUG CARRIER;
FLUORESCENT DYE;
PRODRUG;
ASCORBIC ACID;
CELL SURVIVAL;
CHEMISTRY;
CONFOCAL MICROSCOPY;
DRUG EFFECTS;
HEK293 CELL LINE;
HUMAN;
TUMOR CELL LINE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL;
CANCER INHIBITION;
DRUG ACTIVATION;
DRUG CONJUGATION;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
DRUG MONITORING;
DRUG RELEASE;
DRUG TARGETING;
FLUORESCENCE;
IC50;
MCF 7 CELL LINE;
TARGETED THERANOSTIC DELIVERY SYSTEM;
TUMOR ABLATION;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL SURVIVAL;
CISPLATIN;
DOXORUBICIN;
DRUG CARRIERS;
FLUORESCENT DYES;
HEK293 CELLS;
HUMANS;
MICROSCOPY, CONFOCAL;
PEPTIDES, CYCLIC;
PRODRUGS;
|
EID: 84922420978
PISSN: 13597345
EISSN: 1364548X
Source Type: Journal
DOI: 10.1039/c4cc05255b Document Type: Article |
Times cited : (84)
|
References (24)
|